A researcher in a lab looking at a tablet.

Tag: clinical trial

  • Patient Perspective: Alternative Nuvalent drug for patients disqualified from NVL-655 due to liver toxicity

    Jeff Sturm shares his experience accessing the investigational drug zidesamtinib through a single-patient IND after discontinuing the NVL-655 trial due to liver toxicity. His story highlights how physicians, researchers, and companies sometimes work together to explore additional options for patients.

    Read More

  • ,

    ALK Positive funds two new clinical trials

    November is Lung Cancer Awareness Month, which is a good time to reflect on our successes as an organization. In 2020, we were excited to announce that the ALK Positive/LUNGevity

    Read More

  • ,

    ALK-positive clinical trials & interview with multi-clinical ALK trial participant, Hazel Senz

    Member Hazel Senz from Golden, CO shares her experiences from participating in multiple ALK clinical trials and how they have affected the course of her disease. Hazel Senz has been

    Read More